<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Immature platelet fraction (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IPF</z:e>, %) is a measure of reticulated platelets (RPs), which represents the state of thrombopoiesis </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IPF</z:e> is obtained from an automated hematology analyzer as one of the platelet parameters </plain></SENT>
<SENT sid="2" pm="."><plain>This study was performed to establish reference intervals of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IPF</z:e> and its cut-off values for the differential diagnosis of <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Blood samples from 2,039 healthy individuals (1,161 males, 878 females) were obtained to establish reference intervals </plain></SENT>
<SENT sid="4" pm="."><plain>The patient group included patients with <z:hpo ids='HP_0001973'>idiopathic thrombocytopenic purpura</z:hpo> (<z:chebi fb="0" ids="16039">ITP</z:chebi>) (N=150) and <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (AA) (N=51) with platelet counts of less than 100Ã—10(9)/L </plain></SENT>
<SENT sid="5" pm="."><plain>We evaluated the reliability of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IPF</z:e> measurements, the reference intervals, and cut-off value for the diagnosis of <z:chebi fb="0" ids="16039">ITP</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: The reference intervals of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IPF</z:e> were 0.5-3.2% in males and 0.4-3.0% in females (95% confidence interval) </plain></SENT>
<SENT sid="7" pm="."><plain>The median <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IPF</z:e>% of <z:chebi fb="0" ids="16039">ITP</z:chebi> and AA were 7.7% (range, 1.0-33.8%) and 3.5% (range, 0.6-12.9%), respectively </plain></SENT>
<SENT sid="8" pm="."><plain>Statistical analysis revealed a significant difference between the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IPF</z:e>% of <z:chebi fb="0" ids="16039">ITP</z:chebi> and AA (P&lt;0.0001) </plain></SENT>
<SENT sid="9" pm="."><plain>The cut-off value of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IPF</z:e> for differentiating <z:chebi fb="0" ids="16039">ITP</z:chebi> from AA was 7.3% with a sensitivity and specificity of 54.0% and 92.2%, respectively </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: A rapid and inexpensive automated measurement of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IPF</z:e> can be integrated as a standard parameter to evaluate the thrombopoietic state of the bone marrow </plain></SENT>
<SENT sid="11" pm="."><plain>This study determined the reference intervals of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IPF</z:e> from a large population of healthy individuals, including children </plain></SENT>
<SENT sid="12" pm="."><plain>Further studies are needed to establish the clinical utility of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IPF</z:e> </plain></SENT>
</text></document>